PharmaTech Outlook recently featured PierianDx in it’s December 2017 issue, outlining the groundbreaking role the company has played in advancing NGS testing and precision medicine for healthcare organizations. The article details the evolution of PierianDx’s solution offerings, from the core technology platform, the Clinical Genomics WorkSpace (CGW) supported by its robust knowledgebase, to the company’s addition of validation, interpretation and turnkey lab services.
Click here to download the full article.